FcγR Binding and ADCC Activity of Human IgG Allotypes

Antibody dependent cellular cytotoxicity (ADCC) is an Fc-dependent effector function of IgG important for anti-viral immunity and anti-tumor therapies. NK-cell mediated ADCC is mainly triggered by IgG-subclasses IgG1 and IgG3 through the IgG-Fc-receptor (FcγR) IIIa. Polymorphisms in the immunoglobul...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 740
Main Authors de Taeye, Steven W, Bentlage, Arthur E H, Mebius, Mirjam M, Meesters, Joyce I, Lissenberg-Thunnissen, Suzanne, Falck, David, Sénard, Thomas, Salehi, Nima, Wuhrer, Manfred, Schuurman, Janine, Labrijn, Aran F, Rispens, Theo, Vidarsson, Gestur
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 06.05.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antibody dependent cellular cytotoxicity (ADCC) is an Fc-dependent effector function of IgG important for anti-viral immunity and anti-tumor therapies. NK-cell mediated ADCC is mainly triggered by IgG-subclasses IgG1 and IgG3 through the IgG-Fc-receptor (FcγR) IIIa. Polymorphisms in the immunoglobulin gamma heavy chain gene likely form a layer of variation in the strength of the ADCC-response, but this has never been studied in detail. We produced all 27 known IgG allotypes and assessed FcγRIIIa binding and ADCC activity. While all IgG1, IgG2, and IgG4 allotypes behaved similarly within subclass, large allotype-specific variation was found for IgG3. ADCC capacity was affected by residues 291, 292, and 296 in the CH2 domain through altered affinity or avidity for FcγRIIIa. Furthermore, allotypic variation in hinge length affected ADCC, likely through altered proximity at the immunological synapse. Thus, these functional differences between IgG allotypes have important implications for therapeutic applications and susceptibility to infectious-, allo- or auto-immune diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Eric O. Long, National Institute of Allergy and Infectious Diseases (NIAID), United States
These authors have contributed equally to this work
Reviewed by: Amy W. Chung, The University of Melbourne, Australia; Geoffrey Thomas Hart, University of Minnesota Twin Cities, United States
Present address: Steven W. de Taeye, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.00740